Karyopharm to Report First Quarter 2025 Financial Results on May 12, 2025
Karyopharm Therapeutics (Nasdaq: KPTI), a commercial-stage pharmaceutical company focused on novel cancer therapies, has scheduled its first quarter 2025 financial results announcement for Monday, May 12, 2025. The company will host a conference call and audio webcast at 4:30 p.m. ET to discuss financial results and provide company updates.
Investors can access the conference call via phone at (800) 836-8184 (local) or (646) 357-8785 (international). A live audio webcast with accompanying slides will be available on the company's investor relations website, with an archived version accessible approximately two hours after the event.
Karyopharm Therapeutics (Nasdaq: KPTI), un'azienda farmaceutica in fase commerciale specializzata in terapie innovative per il cancro, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per lunedì 12 maggio 2025. La società terrà una conference call e una webcast audio alle 16:30 ET per discutere i risultati finanziari e fornire aggiornamenti aziendali.
Gli investitori potranno accedere alla conference call telefonando al numero (800) 836-8184 (locale) o (646) 357-8785 (internazionale). Una webcast audio in diretta con slide sarà disponibile sul sito web delle relazioni con gli investitori della società, con una versione archiviata accessibile circa due ore dopo l'evento.
Karyopharm Therapeutics (Nasdaq: KPTI), una compañía farmacéutica en etapa comercial enfocada en terapias novedosas contra el cáncer, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el lunes 12 de mayo de 2025. La empresa realizará una llamada en conferencia y una transmisión de audio en vivo a las 4:30 p.m. ET para discutir los resultados financieros y proporcionar actualizaciones de la compañía.
Los inversionistas pueden acceder a la llamada en conferencia por teléfono marcando (800) 836-8184 (local) o (646) 357-8785 (internacional). Una transmisión de audio en vivo con diapositivas estará disponible en el sitio web de relaciones con inversionistas de la compañía, con una versión archivada accesible aproximadamente dos horas después del evento.
Karyopharm Therapeutics (나스닥: KPTI)는 혁신적인 암 치료제에 중점을 둔 상업 단계 제약 회사로, 2025년 1분기 재무 실적 발표를 2025년 5월 12일 월요일로 예정했습니다. 회사는 재무 실적을 논의하고 회사 업데이트를 제공하기 위해 동부 시간 기준 오후 4시 30분에 컨퍼런스 콜 및 오디오 웹캐스트를 진행할 예정입니다.
투자자들은 (800) 836-8184 (국내) 또는 (646) 357-8785 (국제) 전화번호를 통해 컨퍼런스 콜에 참여할 수 있습니다. 슬라이드와 함께하는 실시간 오디오 웹캐스트는 회사의 투자자 관계 웹사이트에서 제공되며, 이벤트 약 2시간 후에는 녹화본도 이용 가능합니다.
Karyopharm Therapeutics (Nasdaq : KPTI), une société pharmaceutique en phase commerciale spécialisée dans les thérapies innovantes contre le cancer, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le lundi 12 mai 2025. La société organisera une conférence téléphonique et une webdiffusion audio à 16h30 ET pour discuter des résultats financiers et fournir des mises à jour sur l'entreprise.
Les investisseurs peuvent accéder à la conférence téléphonique par téléphone au (800) 836-8184 (local) ou au (646) 357-8785 (international). Une webdiffusion audio en direct accompagnée de diapositives sera disponible sur le site des relations investisseurs de la société, avec une version archivée accessible environ deux heures après l'événement.
Karyopharm Therapeutics (Nasdaq: KPTI), ein Pharmaunternehmen in der kommerziellen Phase mit Fokus auf neuartige Krebstherapien, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für Montag, den 12. Mai 2025 geplant. Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz und eine Audio-Webcast veranstalten, um die Finanzergebnisse zu besprechen und Unternehmensupdates zu geben.
Investoren können die Telefonkonferenz telefonisch unter (800) 836-8184 (lokal) oder (646) 357-8785 (international) verfolgen. Ein Live-Audio-Webcast mit begleitenden Folien wird auf der Investor-Relations-Website des Unternehmens verfügbar sein, eine archivierte Version ist etwa zwei Stunden nach der Veranstaltung abrufbar.
- None.
- None.
-- Conference Call Scheduled for Monday, May 12, 2025, at 4:30 p.m. ET --
To access the conference call, please dial (800) 836-8184 (local) or (646) 357-8785 (international) at least 10 minutes prior to the start time and ask to be joined into the Karyopharm Therapeutics call. A live audio webcast of the call, along with accompanying slides, will be available under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations. An archived webcast will be available on the Company's website approximately two hours after the event.
About Karyopharm Therapeutics
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. Since its founding, Karyopharm has been an industry leader in oral compounds that address nuclear export dysregulation, a fundamental mechanism of oncogenesis. Karyopharm's lead compound and firstinclass, oral exportin 1 (XPO1) inhibitor, XPOVIO® (selinexor), is approved in the
XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc.
View original content to download multimedia:https://www.prnewswire.com/news-releases/karyopharm-to-report-first-quarter-2025-financial-results-on-may-12-2025-302450543.html
SOURCE Karyopharm Therapeutics Inc.
FAQ
When will Karyopharm (KPTI) report Q1 2025 earnings?
How can I access Karyopharm's Q1 2025 earnings call?
Where can I find the webcast of KPTI's Q1 2025 earnings call?
What does Karyopharm Therapeutics (KPTI) do?
